awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34759698-CEE5E261-2EFB-4FEA-BA11-479501D4EACB
Q34759698-CEE5E261-2EFB-4FEA-BA11-479501D4EACB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34759698-CEE5E261-2EFB-4FEA-BA11-479501D4EACB
Issues in the approval of, access to, and post-marketing follow-up of new drugs in Canada: a personal viewpoint.
P2860
Q34759698-CEE5E261-2EFB-4FEA-BA11-479501D4EACB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34759698-CEE5E261-2EFB-4FEA-BA11-479501D4EACB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aaf27e07ca722dcccc316b8371f8a088720f56c2
P2860
Impact of preexisting health conditions on the outcome of an adverse drug reaction alerting program: gastrointestinal disorders before piroxicam and sulindac therapy.